Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $252.66 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $102.09 | 1 | $0 (2021) |
| Amgen Inc. | $73.13 | 3 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $35.54 | 2 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $26.90 | 1 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $15.00 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $2.00 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($2.00) |
| 2022 | $13.00 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($13.00) |
| 2021 | $170.48 | 4 | Abbott Laboratories ($102.09) |
| 2020 | $43.03 | 2 | E.R. Squibb & Sons, L.L.C. ($26.90) |
| 2019 | $24.15 | 1 | Amgen Inc. ($24.15) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/17/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/31/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/16/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: Cardiology | ||||||
| 09/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/15/2021 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $102.09 | General |
| Category: Structural Heart | ||||||
| 05/06/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/01/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $26.90 | General |
| Category: Cardiovascular | ||||||
| 01/22/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Cardiology | ||||||
| 04/29/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,019 | 2,172 | $374,655 | $115,649 |
| 2022 | 13 | 1,107 | 1,330 | $307,317 | $102,190 |
| 2021 | 14 | 1,862 | 2,209 | $355,004 | $116,670 |
| 2020 | 19 | 1,990 | 2,602 | $423,310 | $145,966 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 208 | 223 | $64,391 | $23,412 | 36.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 151 | 220 | $59,772 | $22,599 | 37.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 377 | 397 | $81,810 | $21,183 | 25.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 171 | 172 | $61,765 | $19,183 | 31.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 685 | 719 | $37,618 | $8,806 | 23.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 67 | 67 | $18,586 | $4,271 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 52 | $9,932 | $3,912 | 39.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 50 | $9,450 | $3,497 | 37.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $8,996 | $2,605 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 20 | 20 | $5,775 | $1,724 | 29.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 20 | 20 | $4,909 | $1,272 | 25.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 13 | 13 | $3,606 | $864.37 | 24.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 65 | 65 | $2,707 | $757.69 | 28.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 36 | 36 | $2,251 | $662.04 | 29.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 71 | 77 | $1,836 | $535.51 | 29.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 12 | 12 | $750.24 | $220.68 | 29.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 12 | 12 | $499.80 | $145.92 | 29.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 183 | 339 | $87,716 | $30,142 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 160 | $44,000 | $16,689 | 37.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 127 | 133 | $45,486 | $15,796 | 34.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 221 | 228 | $44,747 | $12,626 | 28.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 37 | 37 | $18,648 | $6,206 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 39 | 48 | $12,994 | $4,190 | 32.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 42 | 57 | $10,260 | $3,533 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $8,862 | $3,175 | 35.8% |
About Dr. Robert Cunnion, MD
Dr. Robert Cunnion, MD is a Cardiovascular Disease healthcare provider based in Fairfax, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508959636.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Cunnion, MD has received a total of $252.66 in payments from pharmaceutical and medical device companies, with $2.00 received in 2023. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($252.66).
As a Medicare-enrolled provider, Cunnion has provided services to 6,978 Medicare beneficiaries, totaling 8,313 services with total Medicare billing of $480,476. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Fairfax, VA
- Active Since 10/02/2006
- Last Updated 11/27/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1508959636
Products in Payments
- Repatha (Biological) $73.13
- XARELTO (Drug) $35.54
- ELIQUIS (Drug) $26.90
- LifeVest (Device) $15.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Fairfax
Abbas Emaminia, Md, MD
Cardiovascular Disease — Payments: $20,669
Gautam Ramakrishna, M.d, M.D
Cardiovascular Disease — Payments: $7,216
Dr. Cristobal Goa, M.d, M.D
Cardiovascular Disease — Payments: $6,651
Dr. Casey Benton, M.d, M.D
Cardiovascular Disease — Payments: $5,867
Michael Banihashemi, Md, MD
Cardiovascular Disease — Payments: $4,723
Dr. Kenneth Brooks, Md, MD
Cardiovascular Disease — Payments: $4,187